NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

中國的Salmeterol/Ticasone市場分析 (2021年∼2025年)

Investigation Report on Chinese Salmeterol/Ticasone Market 2021-2025

出版商 China Research and Intelligence 商品編碼 1006920
出版日期 內容資訊 英文 50 Pages
商品交期: 最快1-2個工作天內
價格
中國的Salmeterol/Ticasone市場分析 (2021年∼2025年) Investigation Report on Chinese Salmeterol/Ticasone Market 2021-2025
出版日期: 2021年05月21日內容資訊: 英文 50 Pages
簡介

中國國內的Salmeterol/Ticasone的銷售額,從2016年到2019年繼續擴大趨勢,2020年達到了約2億9677萬元。但,2020年受到新型冠狀病毒感染疾病 (COVID-19) 感染擴大的影響,自上年度變成21.59%的減少。今後,根據COVID-19結束等市場預計復歸到成長軌道,不過,也能認為受到相關專利的屆滿,多的生物相似藥產品上市。一方面為了大企業的佔有率縮小,產業整體平均價格下降,整體銷售量預計擴大。

本報告提供中國的Salmeterol/Ticasone的市場相關分析,產品的概要和授權情形,整體市場規模趨勢預測,各地區的詳細趨勢,市場價格趨勢預測,主要企業的簡介與市場佔有率,主要的推動及阻礙市場要素等彙整資訊,為您概述為以下內容。

目錄

第1章 Salmeterol/Ticasone的相關概念

  • Salmeterol/Ticasone的適應症
  • 中國國內的Salmeterol/Ticasone的開發趨勢
  • 中國政府的Salmeterol/Ticasone的核準情況
  • COVID-19對中國的Salmeterol/Ticasone銷售的影響

第2章 中國國內的Salmeterol/Ticasone銷售趨勢 (2016年∼2020年)

  • Salmeterol/Ticasone的銷售額
    • 整體銷售額
    • 各地區的銷售額
  • Salmeterol/Ticasone的銷售量
    • 整體銷售量
    • 各地區的銷售量
  • 中國國內的Salmeterol/Ticasone銷售趨勢:各劑型 (2016年∼2020年)
    • 天然氣(氣體) (粉末) 氣霧劑
    • 其他的劑型

第3章 中國的Salmeterol/Ticasone的主要製造商分析 (2016年∼2020年)

  • 主要Salmeterol/Ticasonemeka的市場佔有率分析
    • 市場佔有率:銷售額為基礎
    • 市場佔有率:銷售量為基礎
  • Glaxo Wellcome (舊:the wellcome Foundation)
    • 企業簡介
    • 中國的Salmeterol/Ticasone銷售趨勢
  • GlaxoSmithKline (France)

第4章 中國的Salmeterol/Ticasone的價格趨勢:各主要製造商 (2020年∼2021年)

  • Glaxo Wellcome (舊:the wellcome Foundation) (SERETIDE)
  • GlaxoSmithKline (France) (SERETIDE)

第5章 中國的Salmeterol/Ticasone市場未來展望 (2021年∼2025年)

  • 左右中國的Salmeterol/Ticasone市場趨勢的要素
    • COVID-19對中國的Salmeterol/Ticasone市場的影響
    • 市場促進因素和機會
    • 市場威脅與課題
  • 市場規模的預測
  • 市場趨勢的預測
目錄
Product Code: 2105488

Salmeterol/Ticasone is a compound medication used in regular treatment of asthma and chronic obstructive pulmonary disease (COPD). Its original drug was developed by GlaxoSmithKline. In 2001, Salmeterol Ticasone powder inhalation was approved to enter the Chinese market, and its indication was chronic obstructive pulmonary disease (COPD), and its trade name was SERETIDE; a new indication for asthma was added in China in 2010. SERETIDE powder inhalation has been covered in the category B medical insurance catalogs of 31 provinces, and by 2020 the manufacturers of Salmeterol/Ticasone in China is Glaxo Wellcome(formerly the welcome Foundation) and GlaxoSmithKline(France).

According to CRI's market research, the sales of Salmeterol/Ticasone have had an increasing trend in the Chinese market from 2016 to 2019.The sales revenue in 2020 was approximately CNY296.77million. However, the sales of Salmeterol/Ticasone in 2020 decreased by 21.59% compared with that in 2019 due to the COVID-19 epidemic. The CAGR for Salmeterol/Ticasone is approximately -3.82% from 2016 to 2020.

According to CRI analysis, from 2021 to 2025, the sales of Salmeterol/Ticasone in China will have a recovery growth with the improvement of the epidemic situation and normal operation of overall diagnosis and treatment in hospitals. After the patent for Salmeterol/Ticasone expired, more biosimilar drugs will appear in the market. In China, Respirent Pharmaceuticals Co. Ltd has already submitted an application for Salmeterol/Ticasone in 2021. Therefore, in the next few years, the market share for Glaxo Wellcome (formerly the wellcome Foundation) and GlaxoSmithKline (France) will gradually shrink. At the same time, with the launch of biosimilar drugs, the price will be further reduced. The price adjustment will reduce the burden on patients, thereby increasing the use and sales of Salmeterol/Ticasone.

Topics Covered:

  • The impact of COVID-19 on China's Salmeterol/Ticasone market
  • Sales value of China's Salmeterol/Ticasone 2016-2020
  • Competitive landscape of China's Salmeterol/Ticasone market
  • Prices of Salmeterol/Ticasone in China
  • Prices of Salmeterol/Ticasone in China by regions and manufacturers
  • Analysis on factors affecting the development of China's Salmeterol/Ticasone market
  • Prospect of China's Salmeterol/Ticasone market from 2021 to 2025

Table of Contents

1 Relevant Concepts of Salmeterol/Ticasone

  • 1.1 Indications for Salmeterol/Ticasone
  • 1.2 Development of Salmeterol/Ticasone in China
  • 1.3 Governmental Approval of Salmeterol/Ticasone in China
  • 1.4 The Impact of COVID-19 on Salmeterol/Ticasone sales in China

2 Sales of Salmeterol/Ticasone in China, 2016-2020

  • 2.1 Sales Value of Salmeterol/Ticasone
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Regions
  • 2.2 Sales Volume of Salmeterol/Ticasone
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Regions
  • 2.3 Sales of Salmeterol/Ticasone by Dosage Form in China, 2016-2020

2.3.1Gas (powder) aerosol

    • 2.3.2 Analysis of Other Dosage Forms

3 Analysis of Major Salmeterol/Ticasone Manufacturers in China, 2016-2020

  • 3.1 Analysis of Market Share of Major Salmeterol/Ticasone Manufacturers
    • 3.1.1 Investigation on Market Share by Sales Value
    • 3.1.2 Investigation on Market Share by Sales volume
  • 3.2 Glaxo Wellcome (formerly the wellcome Foundation)
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of SERETIDE (Glaxo Wellcome (formerly the wellcome Foundation)'s Salmeterol/Ticasone) in China
  • 3.3 GlaxoSmithKline (France)
    • 3.3.1 Enterprise Profile
    • 3.3.2 Sales of SERETIDE (GlaxoSmithKline (France)) in China

4 Prices of Salmeterol/Ticasone for Different Manufacturers in China, 2020-2021

  • 4.1 Glaxo Wellcome (formerly the wellcome Foundation) (SERETIDE)
  • 4.2 GlaxoSmithKline (France) (SERETIDE)

5 Prospect of Chinese Salmeterol/Ticasone drug Market, 2021-2025

  • 5.1 Influential Factors of Chinese Salmeterol/Ticasone Market Development
    • 5.1.1 The Impact of COVID-19 on Chinese Salmeterol/Ticasone Market
    • 5.1.2 Market Drivers and Opportunities
    • 5.1.3 Market Threats and Challenges
  • 5.2 Forecast on Market Size
  • 5.3 Forecast on Market Trend

List of Charts

  • Chart Patent Information About Salmeterol/Ticasone Gas (Powder) Aerosol Registration in China
  • Chart Sales Value of Salmeterol/Ticasone Gas (Powder) Aerosol over the World
  • Chart Sales Value of Salmeterol/Ticasone Gas (Powder) Aerosol in China, 2016-2020
  • Chart Sales Value of Salmeterol/Ticasone Gas (Powder) Aerosol in China by Regions, 2016-2020
  • Chart Sales Volume of Salmeterol/Ticasone Gas (Powder) Aerosol in China, 2016-2020
  • Chart Sales Volume of Salmeterol/Ticasone Gas (Powder) Aerosol in China by Regions, 2016-2020
  • Chart Market Share by Sales Value of Top Salmeterol/Ticasone Manufacturers in China, 2016-2020
  • Chart Sales Value and Volume of SERETIDE in China, 2016-2020
  • Chart Referential Prices of SERETIDE in China, 2020-2021
  • Chart Forecast on Sales Value of Salmeterol/Ticasone Gas (Powder) Aerosol in China, 2021-2025
  • Chart Forecast on Sales Volume of Salmeterol/Ticasone Gas (Powder) Aerosol in China, 2021-2025